Effect of nanoparticle with vascular endothelial growth factor gene transferred into ischemic myocardium: Experiment with rabbits

National Medical Journal of China

Volumn 86, Issue 8, 2006, Pages 510-514

  Yi, Fu ^a   Wu, Hong ^a   Jia, Guo Liang ^a   Guo, Wen Yi ^a   Lü, An Lin ^a   Wang, Hai Chang ^a   Zhang, Rong Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial growth factor; Gene therapy; Myocardial ischemia

Indexed keywords

NANOPARTICLE; POLYGLACTIN; SODIUM CHLORIDE; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CELL NUCLEUS; COLLATERAL CIRCULATION; CONTROLLED STUDY; CYTOPLASM; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC CODE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PLASMID; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACOTOMY; VASCULARIZATION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; GENETIC VECTORS; LACTIC ACID; MALE; MYOCARDIAL ISCHEMIA; NANOPARTICLES; POLYGLYCOLIC ACID; POLYMERS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646123301     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kastrup J, Jorgensen E, Ruck A, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol, 2005, 45: 982-988.
2. Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation, 2002, 105: 2012-2018.
3. Vale PR, Losordo DW, Milliken CE, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation, 2001, 103:2138-2143.
4. Rosengart TK, Lee LY, Patel SR, et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg, 1999, 230:466-470.
5. Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol Pharm, 2004, 1:211-219.
6. Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed, 2005, 16:43-56.
7. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 2003, 55: 329-347.
8. Kim IS, Lee SK, Park YM, et al. Physicochemical characterization of poly (L-lactic acid) and poly (D, L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm, 2005, 298:255-262.
9. Avgoustakis K. Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv, 2004, 1:321-333.
10. Chinese source. 2002, 82:341-344.
11. Stern M, Ulrich K, Geddes DM, et al. Poly (D, L-lactide-co-glycolide)/ DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther, 2003, 10:1282-1288.
12. Chinese source. 2003, 15:218-222.
13. Chinese source. 2004, 84:548-553.
14. 165 as sole therapy for myocardial ischemia. Circulation, 1998, 98: 2800-2804.